Neolytix, PrescriberPoint launch shared prior authorization service for mid-market practices

Neolytix and PrescriberPoint said Tuesday they are teaming up to give physician practices a single managed service for prior authorizations, covering both medication and procedure requests from coverage check through appeal. The service starts in November for select specialties and is designed to cut administrative work, reduce denials that go unappealed and help patients start therapy faster.

Why it matters: - Prior authorization remains a major bottleneck for physician practices and patients. - The new service combines software and clinical support in one workflow, which could reduce handoffs when a request needs human review. - Faster resolution of denials can affect whether patients actually receive treatment.

What happened: - Neolytix and PrescriberPoint announced a partnership on Sept. 23, 2026, to offer mid-market physician practices a single managed service for prior authorization. - The service covers medication and procedure requests from the first coverage check through appeal. - The rollout begins in November for Neolytix practice clients. - The first specialties include rheumatology, gastroenterology, pain management and weight management.

The details: - PrescriberPoint’s Prior Authorization platform will automate prescription authorizations that run through the pharmacy benefit plan. - Neolytix clinical specialists will handle medical-benefit authorizations for imaging, procedures and physician-administered drugs. - Neolytix will also handle appeals on both the medication and medical sides. - Physician practices will work with one Neolytix team across the full cycle, with no vendor handoff when a case needs a person. - Patients will receive text updates on authorization status and pharmacy routing from the moment a prescription is written. - Patients will also be enrolled in copay assistance programs. - No app or portal login is required. - The service does not require EHR integration. - Neolytix said it supports more than 300 organizations.

Between the lines: - KFF data cited in the announcement show Medicare Advantage insurers denied 4.1 million prior authorization requests for medical care in 2024. - Nearly nine in 10 of those denials were never appealed. - More than four in five appeals succeeded. - The American Medical Association says physicians and staff spend 13 hours a week on prior authorization. - The AMA also says 40% of physicians have staff who work on nothing else. - More than one in four physicians say prior authorization has led to a serious adverse event for a patient. - Neolytix CEO Raj Bhatnagar said the company sees denials getting resolved when someone has time to work them, but many are never pursued. - PrescriberPoint CEO Dan Cornwell said many prior authorization tools were built for large health systems, while smaller specialty practices face the same burden without the same resources.

What's next: - The partnership will become available to Neolytix practice clients in November. - Neolytix and PrescriberPoint are targeting practices that want faster starts on therapy and fewer administrative delays. - The companies are positioning the service as a way to reduce unresolved denials and lower the workload on practice staff.

The bottom line: - The deal bundles automation, clinical review and appeals into one service, aiming to make prior authorization less fragmented for smaller and mid-market practices.